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Purpose: To evaluate the anti-neuroinflammatory effects of Houttuynia cordata extract (H. cordata) in 
lipopolysaccharide (LPS)-stimulated BV-2 microglial cells, and its anti-oxidant properties.  
Methods: Anti-oxidant properties were evaluated by 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) radical 
scavenging assay. Cell viability was assessed by 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium 
bromide (MTT) assay. LPS was used to stimulate BV-2 cells. Nitric oxide (NO) levels were measured 
using Griess assay. Inducible NO synthase (iNOS) expression, interleukin (IL)-6 expressional level were 
determined by enzyme-linked immunosorbent assay (ELISA) and Western blot analysis.  
Results: Ethyl actetae (HC-EA) extract of H. cordata significantly scavenged DPPH free radicals in a 
concentration-dependent fashion. The increased levels of NO, iNOS and IL-6 in LPS-stimulated BV-2 
microglial cells were also suppressed by HC-EA extract in a concentration-dependent manner.  
Conclusion:The result indicate that the HC-EA extract exhibited strong anti-oxidant properties and 
inhibited the excessive production of pro-inflammatory mediators, including NO, iNOS and IL-6, in LPS-
stimulated BV-2 cells. The anti-oxidant phenolic compounds present in HC-EA extract might play an 
important role in ameliorating neuroinflammatory processes in LPS-stimulated BV-2 microglial cells.  
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Inflammation in brain disorders is characterized 
by activation of glial cells (mainly microglia and 
astrocytes) further expressing key inflammatory 
mediators as well as neurotoxic free radicals. 
Microglia are the resident immune cells of the 
central nervous system which show increased 
inflammatory activity (i.e. neuroinflammation) by 
infections, cerebral ischemia, traumatic brain 
injury, or neuronal/parenchyma damage [1]. 
Activation of microglia and subsequent release of 
pro-inflammatory mediators including nitric oxide 
(NO), inducible NO synthase (iNOS), IL-1β, IL-6 
and TNF-α, progressively increase during normal 
aging and are also commonly present in neuro-
degenerative diseases [2].  
 
It is well known that lipopolysaccharide (LPS)-
stimulated microglia releases various pro-
inflammatory and neurotoxic factors and is 
recognized to be a useful in vitro model for the 
studying mechanisms related to neuronal injury-
mediated inflammatory processes [3]. Therefore, 
regulation of microglial activation may have 
therapeutic benefits that lead to alleviating 
neuroinflammatory diseases. Houttuynia cordata 
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(H. cordata), a grass from the Saururaceae 
family is a perennial herb native to Southeast 
Asia and has immense medicinal values. 
Traditionally, H. cordata is used in folk medicine 
for diuresis and detoxification, as well as an anti-
viral, anti-bacterial and anti-leukemic agent [4]. It 
is also known to be promisingly effective drug for 
allergic inflammation [5] and anaphylaxis [6]. 
Recently, it was used to tackle severe acute 
respiratory syndrome (SARS) as it is 
conventionally used to treat pneumonia [7]. 
However, the anti-neuroinflammatory activity of 
H. cordata has not been studied in activated BV-
2 microglial cells. In this study, we sought to 
determine whether H. cordata extract possesses 
anti-neuroinflammatory activity in LPS-stimulated 
BV-2 microglial cells. In addition, its anti-oxidant 
potential was  evaluated to see if it is  consistent 




Preparation of the H. cordata extract  
 
Dried H. cordata was purchased from the 
traditional herb market and was authenticated by 
a taxonomist at Konkuk University, South Korea. 
A voucher specimen (K-KU-2013) was kept in 
our department herbarium for future reference. 
To obtain the H. cordata extract, the dried plant 
material was ground in a mixer and defatted 
three times with three volumes of ethanol. The 
residue was extracted with absolute ethanol at 
1:10 ratio (w/v) for 2 h in heating mantle at 70 ~ 
80 °C. The supernatant was filtered and 
concentrated in a rotary evaporator at 50 °C. For 
further fractionation, the alcoholic extract (50 g) 
was partitioned into hexane, ethyl acetate (EA), 
and n-butanol fractions to yield 0.53, 8.72 and 
38.25 g, respectively.  The EA fraction of H. 
cordata (HC-EA) with potent antioxidant 
properties was re-dissolved in distilled water and 
used for evaluating its anti-neuroinflammatory 
and anti-oxidant properties. 
 
DPPH radical scavenging activity  
 
The anti-oxidant property of the HC-EA extract 
was determined using the stable radical 2, 2-
diphenyl-1-picrylhydrazyl (DPPH, Sigma-Aldrich, 
St. Louis, MO, USA). The radical scavenging 
capacity was evaluated by employing a reaction 
mixture constituted by aliquots of the HC-EA 
extract and a DPPH methanolic solution as 
described previously [8]. Briefly, a sample 
solution of 60 µl of each concentration of HC-EA 
extract, was added to 60 µl of DPPH (60 µM) in 
methanol. After mixing vigorously for 10 s, the 
mixture was then transferred into a 100 µl Teflon 
capillary tube and the scavenging activity of each 
sample on DPPH radical was measured using a 
JES-FA ESR spectrometer (Jeol Ltd., Tokyo, 
Japan). A spin adduct was measured on an ESR 
spectrometer exactly after 2 min. Experimental 
conditions were as follows: central field, 3,475 G; 
modulation frequency, 100 kHz; modulation 
amplitude, 2 G; microwave power, 5 mW; gain, 
6.3 x 105, and temperature, 298 °K. 
 
Cell culture and viability assay 
 
BV-2 microglia cells were cultured at 37 °C in 5 
% CO2 in DMEM (Invitrogen, Carlsbad, CA, 
USA) supplemented with 5% FBS (Hyclone, 
Logan, UT, USA) and antibiotics (Invitrogen). In 
all experiments, cells were pre-treated with the 
indicated concentrations of HC-EA) for 1 hr 
before the addition of LPS (1 µg/ml, Sigma-
Aldrich, St. Louis, MO, USA) in serum free 
DMEM. An equal volume of sterile water was 
added to all control treatments.  
 
For viability assay, 3-(4, 5-dimethylthiazol-2-yl)-
2,5- diphenyl-tetrazolium bromide (MTT, Sigma-
Aldrich, St. Louis, MO, USA) assay was used as 
described previously [9]. Briefly, BV-2 cells were 
plated onto 96 well plates and exposed to EA-
OFP extract. MTT was added to each well then 
incubated for additional 2 hr in dark at 37°C. The 
medium was then aspirated from the wells and 
the blue formazan product obtained was 
dissolved in DMSO. The plates were analyzed at 
570 nm using a microplate reader (Tecan 
Trading AG, Switzerland). Each experiment was 
conducted in triplicate. Percentage of the cell 
viability was calculated as (absorbance of extract 
treated sample/absorbance of non-treated 
sample) x 100 %.  
 
Assay of NO  
 
Production of NO was assayed by measuring the 
levels of nitrite in the culture supernatant using 
colorimetric assay with Griess reagent [10]. 
Briefly, BV-2 cells (2 x 105 cells/ml) were seeded 
in 6-well plates in 500 l complete culture 
medium and then were stimulated with LPS (1 
µg/ml) for 2 h. Fifty microliters of culture 
supernatant reacted with an equal volume of 
Griess reagent (0.1% naphthylethylenediamine 
and 1 % sulfanilamide in 5 % H3PO4) in 96 well 
plates at room temperature in the dark. Nitrite 
concentrations in the culture supernatant were 
determined by using standard solutions of 
sodium nitrite. The absorbance was read at 540 
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Immunoblot analysis and antibodies  
 
Cells were washed in cold PBS and lysed in 
buffer containing 50 mM Tris-HCl, pH 7.4, 1 
%(v/v) NP-40, 0.25 % sodium deoxycholate, 
150mM NaCl, 1mM EDTA, 25mM NaF, 2 mM 
Na3VO4 and protease inhibitor cocktail (Complete 
Mini, Roche, Manheim, Germany) at 4 °C. The 
lysate was clarified by centrifugation at 10,000 g 
for 20 min at 4 °C to remove insoluble 
components. Cell lysates were normalized for 
protein content using BCA reagent (Pierce, 
Rockford, IL, USA). Equal amounts of protein 
were loaded onto 10 % PAGE gels and 
separated by standard SDS-PAGE method. 
Proteins were transferred to an NC membrane 
(S&S, Dassel, Germany) and blocked with 5% 
non-fat dry milk in TBS. To detect protein 
expression, the blots were probed with the 
specific antibodies against iNOS, followed by the 
secondary antibodies coupled to horseradish 
peroxidase (Bio-Rad, Hercules, CA, USA). The 
detection of β-actin with a specific antibody was 
used as an internal control. The immunoreactive 
proteins on the membrane were detected by 
chemiluminescence using the West-Save 
substrate (Lab-Frontier, Seoul, Korea) on x-ray 
film. The antibodies against iNOS and β-actin 
were purchased from Cell Signaling Technology 
(Beverly, MA, USA). 
 
IL-6 assay  
 
BV-2 microglia cells (1 x 105 cells/well) were 
cultured on 96 well plates and treated with HC-
EA extract at indicated dosages and LPS 
(1µg/ml). At 4 hr  post-LPS treatment, the cells 
were collected and the supernatants were used 
to estimate IL-6 contents using a murine IL-6 
ELISA kit from BD Biosciences (San Jose, CA, 




All data are represented as the mean ± SEM of 
at least three independent experiments.. 
Statistical analyses were performed using SAS 
statistical software (SAS Institute, Cray, NC, 
USA) using Student’s t test. P < 0.05 was 




Effect of HC-EA extract on DPPH radical 
scavenging activity   
 
As shown in Fig. 1, HC-EA exhibited significant 
DPPH radical scavenging activity in a 
concentration-dependent manner showing a 
maximum effect at 100 µg/ml of  (p<0.001).  
 
Effect of HC-EA extract on BV-2 cell viability 
 
The cytotoxicity of HC-EA extract was evaluated 
based on its effects on cell growth using MTT 
assay (>95% cell viability).  Treatment with HC-
EA at various concentrations (0.1 µg/ml to 100 
µg/ml) did not affect the overall cell viability nor 
did they exhibit any significant cytotoxicity in BV-
2 microglia (Fig 2).  
 
 
Fig 1: Effect of HC-EA extract on DPPH radical 
scavenging activity. Data are presented as mean ± 
SEM (n = 3) for three independent experiments; *p < 
0.05 and ***p < 0.001, compared with control group by 
Student t-test. HC-EA= Houttuynia cordata ethyl  
acetate extract 
 
Fig 2: Effect of HC-EA extract on the viability of BV-2 
microglial cells. Data are presented as mean ± SEM (n 
= 3); HC-EA = Houttuynia cordata ethyl acetate extract 
 
HC-EA extract attenuates NO production in 
LPS-stimulated BV-2 cells 
 
As shown in Fig. 3, cells treated with LPS alone 
significantly increased NO levels (p < 0.001). 
However, pre-treatment with HC-EA extract 
significantly suppressed the LPS-stimulated 
increased NO release in BV-2 cells in a 
concentration-dependent manner compared to 
LPS cells. The maximum effect was observed at 
80 µg/ml  (p<0.001). The other concentrations of 
HC-EA (10, 20 and 40 µg/ml) also significantly 
(p<0.01, p<0.001 and p<0.001, respectively) and 
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concentration-dependently inhibited the release 
of NO in LPS-stimulated BV-2 cells. 
 
HC-EA extract attenuates iNOS expressional 
levels in LPS-stimulated BV-2 cells  
 
Western blot analysis showed that the increased 
protein expression of iNOS in the LPS-stimulated 
BV-2 cells was also suppressed in a 
concentration-dependent manner (Fig 4). 
Although LPS-stimulated BV-2 cells are 
associated with the increased iNOS expression, 
pre-treatment with HC-EA extract suppressed 
increased iNOS protein expressional levels with 
maximum effect at 80 µg/ml concentration.  
 
 
Fig 3: Effect of HC-EA extract on NO Production in 
LPS-stimulated BV-2 microglial cells. Data are 
presented as mean ± S.E.M. (n = 3) for three 
independent experiments; #p < 0.001, when compared 
with control group. **p < 0.01 and ***p < 0.001, when 
compared with LPS-treated group; HC-EA = 
Houttuynia cordata - ethyl acetate. 
 
Fig 4: Effect of HC-EA extract on iNOS expressional 
levels in LPS-stimulated BV-2 microglial cells. HC-EA 
= Houttuynia cordata ethyl acetate extract 
 
Effect of HC-EA extract on IL-6 production in 
LPS-stimulated BV-2 cells   
 
The level of IL-6 increased significantly after LPS 
(1 µg/ml) treatment when compared to those in 
the control group. However, HC-EA extract 
significantly reduced IL-6 production in a 





Activation of microglia and the subsequent 
release of inflammatory cytokines and toxic free 
radicals are  the hallmarks of neuroinflammation 
observed in several neurodegenerative diseases 
[1,2]. Microglial activation in response to LPS is 
well documented and it generates numerous pro- 
and anti-inflammatory mediators  [11,12]. Recent 
studies have shown that anti-oxidant and anti-
inflammatory agents may suppress microglial 
activation and thus protect neuronal cell death 




Fig 5: Effect of HC-EA extract on pro-inflammatory 
cytokine IL-6 expression in LPS-stimulated BV-2 cells. 
Data are presented as mean ± SEM (n = 3); #p < 
0.001, compared with control group; **p < 0.01, ***p < 
0.001, compared with LPS alone treated group; HC-
EA= Houttuynia cordata ethyl acetate extract 
 
H. cordata, a traditional plant is used as folk 
medicine for treating several diseases including 
allergic inflammation and anaphylaxis [4-6]. 
However, not much is known about the anti-
neuroinflammatory activities of H. cordata extract 
in activated BV-2 microglial cells in vitro . The 
results of this study show that HC-EA extract 
suppressed the inflammatory mediators such as 
NO, iNOS and IL-6 in LPS-stimulated BV-2 
microglial cells and exhibited strong anti-oxidant 
effects.  
 
It is well documented that activated microglia can 
produce several potentially neurotoxic 
substances, including NO synthesized by iNOS. 
iNOS, an important mediator of inflammation 
speeds up the production of NO. NO which is a 
neurotransmitter in the CNS has protective 
functions in anti-inflammatory pathways but at 
high concentrations produces nitrite free radicals 
which are neurotoxic [15]. In our study, it was 
observed that HC-EA extract significantly 
suppressed nitrite production in LPS-stimulated 
BV-2 cells in concentration-dependent manner. 
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Further, HC-EA extract attenuated the increased 
iNOS protein levels in LPS-stimulated BV-2 cells, 
suggesting that HC-EA extract has potent anti-
neuroinflammatory benefits through the 
suppression of increased NO production and 
iNOS expression. 
Pro-inflammatory cytokines such as TNF-α, IL-1β 
and IL-6 cause potent activation of iNOS gene 
expression in rodent glial cells and muscle cells 
[16]. In particular, the involvement of IL-6 in 
inflammatory process has been highly 
recognized as targets of therapeutic intervention 
as IL-6 not only amplifies the inflammatory 
cascade, but also causes inflammatory injury 
[16,17]. The likelihood of the involvement of HC-
EA extract in attenuating such factor is supported 
by our observations that pro-inflammatory 
mediator IL-6 produced by LPS stimulation was 
significantly suppressed by HC-EA in BV-2 
microglial cells indicating that HC-EA may  be an 
effective anti-neuroinflammatory agent.  
 
Polyphenolic compounds are powerful anti-
oxidants and are widely known to have  
protective effect against several human diseases 
including neurodegenerative diseases [18]. 
Therefore to identify whether the polyphenolic 
compounds present in HC-EA extract possess 
anti-oxidant actions, we estimated using the 
DPPH free radical scavenging assay. DPPH 
radical assay is one of the widely used methods 
for screening the free radical scavenging 
activities of several anti-oxidants in a relatively 
short period of time [8]. In our study HC-EA 
significantly scavenged the DPPH free radicals, 
indicating that the extract has anti-
neuroinflammatory effects in LPS-stimulated BV-
2 cells. Previous reports indicated that essential 
oils from H. cordata contain several agents such 
as β-myrcene, β-pinene, α-pinene, α-terpineol 
and n-decanoic acid [19]. Reports also exists that 
H. cordata contains polyphenolic compounds 
such as chlorogenic acid, quercetin-3-O-β-d-
galactopyranosyl-7-O-β-d-glucopyranoside, 
quercetin 3-O-α-l-rhamnopyra-nosyl-7-O-β-d-
glucopyranoside, rutin, hyperin, isoquercitrin, 
quercitrin, afzelin, piperolactam A, and 
aristolactam B [19]. These antioxidant 
polyphenolic compounds present in HC-EA 
extract might be responsible for its  potent anti-





Our findings suggest that HC-EA extract acts by 
suppressing the expression of inflammatory 
mediators such as NO, iNOS and IL-6 in LPS-
stimualetd BV-2 cells and also inhibits free 
radicals which are involved in the inflammatory 
events. Therfore, HC-EA extract may be 
developed as a potential therapeutic agent in 
treating microglia-mediated neuroinflammatory 
diseases.  
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